Pharmaceutical Blood Products
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Biopharmaceuticals".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 6
Special Issue Editors
Interests: albumin; liposome; drug delivery; enhanced permeability retention effect; protein; functionalization of plasma proteins for pharmaceutical applications
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacology; toxicology; pharmaceutics
Special Issues, Collections and Topics in MDPI journals
Interests: interdisciplinary science and engineering; nano/micro science; nanobioscience medicine; dentistry; pharmacy; drug development chemistry; medical pharmacy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pharmaceutical blood products represent a critical class of biopharmaceuticals derived from human blood or plasma, playing an indispensable role in modern medicine. These life-saving therapeutics encompass a diverse range, including plasma-derived medicinal products (e.g., immunoglobulins, albumin, and coagulation factors), recombinant blood factors, and cellular therapies. They are vital for treating a multitude of conditions, such as immunodeficiencies, bleeding disorders like hemophilia, severe burns, and various autoimmune diseases.
The field is continuously evolving, driven by advancements in fractionation technologies, viral inactivation methods, and the development of novel recombinant and gene-editing approaches that enhance safety, efficacy, and availability. Despite significant progress, challenges persist, including ensuring global supply, managing the risk of pathogen transmission, and optimizing production processes. This Special Issue aims to explore the latest advancements, innovative research, and clinical applications of pharmaceutical blood products. We invite original research articles, reviews, and short communications covering topics such as novel product development, manufacturing processes, quality control, safety profiles, clinical efficacy, and emerging therapies in this vital area of pharmaceutical science.
Dr. Victor Tuan Giam Chuang
Prof. Dr. Masaki Otagiri
Prof. Dr. Kazuaki Taguchi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmaceutical blood products
- plasma-derived therapeutics
- recombinant blood factors
- cellular therapies
- immunoglobulins
- fractionation technologies
- viral inactivation
- hemophilia treatments
- gene-editing approaches
- clinical efficacy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
